Bachrodt Amy's Form 4 filing
Maze Therapeutics, Inc. (MAZE) · filed Dec 31, 2025
- Accession no.
- 0002050422-25-000007
- Filed
- Dec 31, 2025
- Trade date
- Dec 29-30, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 4 derivative transactions. Open-market sales total $606.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bachrodt AmyCIK 0002050422 | Officer (SVP, Finance) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 29, 2025 | Common Stock | MOption exerciseAcquired | +124 | $10.42 | +$1,292.08 | 13,089 | Direct | |
| Dec 29, 2025 | Common Stock | MOption exerciseAcquired | +9,876 | $10.42 | +$102,907.92 | 22,965 | Direct | |
| Dec 29, 2025 | Common Stock | SSaleDisposed | −9,400 | $40.54 | −$381,076 | 13,565 | Direct | |
| Dec 29, 2025 | Common Stock | SSaleDisposed | −600 | $41.16 | −$24,696 | 12,965 | Direct | |
| Dec 30, 2025 | Common Stock | MOption exerciseAcquired | +2,395 | $10.42 | +$24,955.9 | 15,360 | Direct | |
| Dec 30, 2025 | Common Stock | MOption exerciseAcquired | +2,605 | $10.42 | +$27,144.1 | 17,965 | Direct | |
| Dec 30, 2025 | Common Stock | SSaleDisposed | −5,000 | $40.08 | −$200,400 | 12,965 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 29, 2025 | Common Stock | MOption exerciseDisposed | −124 | $0.00 | $0 | 2,396 | Direct | |
| Dec 29, 2025 | Common Stock | MOption exerciseDisposed | −9,876 | $0.00 | $0 | 23,834 | Direct | |
| Dec 30, 2025 | Common Stock | MOption exerciseDisposed | −2,395 | $0.00 | $0 | 1 | Direct | |
| Dec 30, 2025 | Common Stock | MOption exerciseDisposed | −2,605 | $0.00 | $0 | 2,581 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.